"I love New Era of Revolutionary Vaccines | Novavax"

2022-05-07 21:23:20

Skip to main content Science & technology Science & technologyNovavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.OverviewOur pipelineMatrix-M™ adjuvantRecombinant, protein-based nanoparticle vaccineGlobal vaccine approval/authorization mapCOVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.Learn more about our COVID-19 updates Who we are Who we areWe are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.Our companyExecutive leadershipSenior management teamBoard of directorsOur partnersBuild your future with usJoin other passionately curious people who are bringing innovative vaccines to the worldDiscover career opportunities Insights InsightsNovavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.ArticlesDiversity matters: Inclusivity in clinical trialsFrom pandemic to endemic: Why COVID-19 may be here to stayStanding on the shoulders of giants: How a Novavax vaccine is developed Medical professionals News & media Investors Careers Science & technology Overview Our pipeline Matrix-M™ adjuvant Recombinant, protein-based nanoparticle vaccine Global vaccine approval/authorization map Who we are Our company Executive leadership Senior management team Board of directors Our partners Insights Articles Diversity matters: Inclusivity in clinical trials From pandemic to endemic: Why COVID-19 may be here to stay Standing on the shoulders of giants: How a Novavax vaccine is developed Medical professionals News & media Investors Careers A NEW ERA OF VACCINESLatest press release on vaccine candidatesView press releasesCOVID-19 vaccine research updatesNovavax COVID-19 vaccine (recombinant, adjuvanted) is now conditionally authorized in several regionsLatest update2 billiondoses per yearat full capacity10+ yearsof nanoparticlevaccine development1,500+employeesworldwide6areas ofresearchNovavax information for:General publicMedical professionalsInvestorsCareer seekersNovavax information for:General publicMedical professionalsInvestorsCareer seekersNEWS & MEDIANovavax Announces Launch of Global Vaccine Education ProgramsFull press releaseNEWS & MEDIACurrent Protocol for Phase 3 Clinical Trial of NVX-CoV2373 in the U.S. and MexicoFull press releaseNovavax first quarter 2022 financial resultsBrowse the calendar and sign up to view investor-related events and announcements. Webcasts and presentations that have been archived are also available by viewing historical event details.Latest quarterly earningsLearn more about earningsLatest investor presentationDownload2021 annual reportDownloadNASDAQ:NVAXLoading data...Stock detailsVisit our investor hubExplore current opportunities in:United StatesCzech RepublicSwedenEuropeAsia-Pacific183jobs availableat NovavaxI’m most inspired by our global impact.Together, we can help improve the lives of people around the world.Leslie HarrisonSenior HR Information Systems SpecialistLearn more about our cultureInsightsWhy do we need vaccine booster injections?Review the articleScience & technologyOur pipeline—creating tomorrow's vaccines todayExplore our pipelineWho we areNovavax is powered by global collaborationsLearn about our partners Science & technology Overview Our pipeline Recombinant nanoparticle vaccine technology Matrix-M™ adjuvant technology Global vaccine approval/authorization map Who we are Our company Executive leadership Senior management team Board of directors Our partners More information Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted) Global medical information site Ask medical questions, report adverse events, and product quality complaints Contact us Connect with us Sign up for updates Careers 183Current opportunitiesNovavax is proud to be recognized by the 2021 Top Workplaces USA, reflecting our dedication to an exceptional work cultureExplore current opportunities in: USA CZ SE EUR APAC COR-GL-ALL-00043/22 © 2022 Novavax. All rights reserved. Privacy Policy Cookies Policy Terms and Conditions Site Map Pay Transparency Nondiscrimination Provision Purchase Order Terms and Conditions You are leaving novavax.com You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Novavax provides this link as a service to website visitors. Novavax is not responsible for the privacy policy of any third-party websites. Continue Cancel This Novavax website is for medical professionals only. Click "Continue" only if you are a medical professional. Continue Cancel You are leaving novavax.com You have selected a link that will take you to a site maintained by a third party. Novavax is not responsible for the Privacy Policy of any third-party websites. Continue Cancel